---
title: "Phillip Securities Remains a Buy on Shanghai Chicmax Cosmetics Co., Ltd. Class H (2145)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279113194.md"
description: "Phillip Securities has maintained a Buy rating on Shanghai Chicmax Cosmetics Co., Ltd. Class H, setting a price target of HK$78.64, while the shares closed at HK$56.35. The overall analyst consensus for the company is a Strong Buy, with an average price target of HK$103.06."
datetime: "2026-03-14T05:15:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279113194.md)
  - [en](https://longbridge.com/en/news/279113194.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279113194.md)
---

# Phillip Securities Remains a Buy on Shanghai Chicmax Cosmetics Co., Ltd. Class H (2145)

Phillip Securities analyst maintained a Buy rating on Shanghai Chicmax Cosmetics Co., Ltd. Class H yesterday and set a price target of HK$78.64. The company’s shares closed yesterday at HK$56.35.

### Claim 70% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Shanghai Chicmax Cosmetics Co., Ltd. Class H with a HK$103.06 average price target.

### Related Stocks

- [02145.HK](https://longbridge.com/en/quote/02145.HK.md)

## Related News & Research

- [Sinolink Securities Sticks to Their Buy Rating for Shanghai Chicmax Cosmetics Co., Ltd. Class H (2145)](https://longbridge.com/en/news/269473323.md)
- [Earnings Beat: Deepak Nitrite Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models](https://longbridge.com/en/news/286980047.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)
- [Analyst Reiterates Buy on Dermata, Keeps 12-Month Price Target Unchanged at $4](https://longbridge.com/en/news/286958909.md)